The Academic Medical Center, or AMC, is the university hospital affiliated with the University of Amsterdam. It is one of the largest and leading hospitals of the Netherlands, located in the Bijlmer neighborhood in the most south-eastern part of the city of Amsterdam.

There are 1,002 (2011) beds in Academisch Medisch Centrum; Hematologie.

During the past decade, Academisch Medisch Centrum; Hematologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Academisch Medisch Centrum; Hematologie" are "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Follicular Lymphoma" (1 trials), "Leukemia, Myeloid, Acute" (1 trials) and "Non-Hodgkins Lymphoma" (1 trials). Many other conditions were trialed in "Academisch Medisch Centrum; Hematologie" in a lesser frequency.

Most popular intervention types in "Academisch Medisch Centrum; Hematologie" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Polatuzumab Vedotin" (2 trials), "Rituximab" (2 trials), "Cytarabine" (1 trials), "Idasanutlin" (1 trials) and "Obinutuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Academisch Medisch Centrum; Hematologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Academisch Medisch Centrum; Hematologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Academisch Medisch Centrum; Hematologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Academisch Medisch Centrum; Hematologie, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".